Inspire medical systems, inc. (INSP)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Operating activities
Net loss

-41,222

-33,243

-28,941

-25,387

-23,593

-21,828

-21,301

-20,631

-19,531

-17,511

0

0

0

Adjustments to reconcile net loss:
Depreciation and amortization

579

495

447

414

406

393

399

374

332

285

0

0

0

Accretion of investment discount

754

983

1,494

1,257

957

648

0

0

0

-

-

-

-

Accretion of debt discount

212

268

326

390

465

568

540

508

467

315

0

0

0

Non-cash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

Stock-based compensation expense

7,555

6,197

4,827

3,675

2,555

1,219

750

459

244

243

0

0

0

Non-cash stock issuance for services rendered

247

233

232

211

153

95

0

0

0

-

-

-

-

Change in the fair value of preferred stock warrants

-

-

-

-

-

-595

0

0

0

-

-

-

-

Other, net

91

143

92

90

90

-51

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

4,003

6,480

5,662

5,007

3,620

2,836

2,214

1,973

1,180

1,767

0

0

0

Inventories

4,139

3,167

1,600

13

-288

-1,003

32

538

201

315

0

0

0

Prepaid expenses and other current assets

342

905

2,574

4,960

-647

1,326

833

846

2,022

308

0

0

0

Accounts payable

2,628

1,034

2,432

447

-701

439

831

895

2,616

1,825

0

0

0

Accrued expenses and other liabilities

1,708

2,944

2,740

1,609

1,148

3,581

1,746

2,101

1,608

1,342

0

0

0

Net cash used in operating activities

-36,679

-32,846

-29,359

-29,968

-23,218

-18,694

-19,382

-18,956

-16,849

-15,791

0

0

0

Investing activities
Purchases of property and equipment

2,719

2,739

2,488

1,424

518

250

121

245

213

412

0

0

0

Purchases of investments

152,408

178,074

160,069

211,380

151,412

115,481

0

0

0

-

-

-

-

Proceeds from sales or maturities of investments

162,853

137,254

142,612

101,326

84,072

32,342

0

0

0

-

-

-

-

Net cash provided by investing activities

7,726

-43,559

-19,945

-111,478

-67,858

-83,389

-89,459

-2,351

-6,969

-7,600

0

0

0

Financing activities
Proceeds from issuance of notes payable

-

-

-

-

-

8,000

8,000

8,000

8,000

458

0

0

0

Payment of debt fees

0

531

531

531

531

0

0

0

0

-

-

-

-

Proceeds from the exercise of stock options and warrants

1,762

1,140

1,088

941

538

558

571

612

414

235

0

0

0

Proceeds from sale of preferred stock

-

-

-

-

-

-

-

-

-

24,968

0

0

0

Net cash provided by (used in) financing activities

3,117

1,964

70,977

70,831

181,832

190,383

120,613

120,653

8,414

25,661

0

0

0

Effect of exchange rate on cash

8

13

59

30

42

33

0

0

0

-

-

-

-

Increase in cash and cash equivalents

-25,828

-74,428

21,732

-70,585

90,798

88,333

11,772

99,346

-15,404

2,270

0

0

0

Supplemental cash flow information
Cash paid for interest

1,733

2,033

2,128

2,213

2,443

2,019

1,792

1,573

1,362

1,323

0

0

0

Issuance of preferred stock warrants

-

-

-

-

-

103

103

103

103

4

0

0

0